Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.

“Medication adherence and discontinuation present a major challenge in the treatment of schizophrenia and schizoaffective disorder,” said Rongbing Yang, President of Luye Pharma Group.

Clinical psychologist, Dr. Corey Gonzales talks about the prevalence and content of auditory and visual hallucinations within ...

A woman involved in a wild brawl inside a 7-Eleven store has broken her silence for the first time as a coroner probes an ...

Luye Pharma launches Erzofri ER injectable suspension to treat schizophrenia and schizoaffective disorder in US market: Princeton, New Jersey Tuesday, April 8, 2025, 15:00 Hrs [IS ...

A newer and innovative form of relational therapy is AVATAR Therapy. This approach works by “embodying” the voice through a ...

The city of Albuquerque has agreed to pay $2.5 million to a man who was permanently disabled after being shot by an officer during a schizoaffective episode. The city's decision to settle came ...